№ lp_2_3_21112
File format: docx
Character count: 34538
File size: 88 KB
A contact list for personnel involved in the Gonococcal Isolate Surveillance Project across various sentinel clinics and regional laboratories in the United States.
Year:
2013
Region / City:
Albuquerque, New Mexico; Atlanta, Georgia; Austin, Texas; Baltimore, Maryland; Birmingham, Alabama; Chicago, Illinois
Theme:
Gonococcal Isolate Surveillance
Document Type:
Address List
Organization:
New Mexico Department of Health; Georgia Department of Public Health; Texas Department of State Health Services; Baltimore City Health Department; Alabama Department of Public Health
Author:
Robert Kirkcaldy, Project Officer
Target Audience:
Healthcare professionals, public health officials
Effective Period:
2013
Approval Date:
2013
Document Modification Date:
N/A
Note:
Description
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2020
Country:
Australia
Programme:
Australian Gonococcal Surveillance Programme (AGSP)
Network:
National Neisseria Network
Established:
1981
Subject:
Antimicrobial resistance in Neisseria gonorrhoeae
Pathogen:
Neisseria gonorrhoeae
Data source:
Clinical isolates from public and private sectors
Number of isolates tested:
7,219
Antimicrobials tested:
Ceftriaxone; Azithromycin; Penicillin; Ciprofloxacin; Spectinomycin; Tetracycline; Gentamicin
Testing method:
In vitro antimicrobial susceptibility testing using standardised methods
Jurisdictions covered:
All Australian jurisdictions
Notifiable system:
National Notifiable Diseases Surveillance System (NNDSS)
Authors:
Monica M Lahra; Tiffany R Hogan; Masoud Shoushtari; Benjamin H Armstrong
Published online:
28 October 2021
DOI:
10.33321/cdi.2021.45.58
Keywords:
Antimicrobial resistance; Disease surveillance; Gonococcal infection; Neisseria gonorrhoeae
Year:
2021
Region / City:
Global
Topic:
Metagenomic analysis, virus identification
Document type:
Scientific research article
Institution:
N/A
Author:
N/A
Target audience:
Researchers, virologists
Effective period:
N/A
Approval date:
N/A
Modification date:
N/A
Year:
2023
Region / City:
Not specified
Topic:
Rheology, Food Science
Document Type:
Research Article
Author:
Not specified
Target Audience:
Researchers, Food Scientists
Period of Validity:
Not applicable
Approval Date:
Not specified
Date of Changes:
Not specified
Product name:
Cannabinol (CBN) Isolate
Product code:
M01
Brand:
Breathe Life Sciences Ltd
Company:
Breathe Life Sciences Ltd
Company address:
Grand Union Studios, 332 Ladbroke Grove, London, England, W10 5AD
Customs number:
3301.3000
CAS number:
521-35-7
Chemical formula:
6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol
Molecular weight:
310.4
Substance origin:
Derived from natural sources
Process:
Controlled conversion of natural cannabinoids through enzymatic pathways
Quantity range:
1 g – 1 kg
Hazard classification:
GHS07 Harmful; GHS08 Respiratory sensitization risk from airborne dust
Hazard statements:
H302 Harmful if swallowed; H413 May cause long lasting harmful effects to aquatic life
Regulatory framework:
Regulation (EU) 1272/2008 (CLP)
REACH status:
Registration not available or not required at current tonnage
Applications:
Basic raw material for chemical industry, cosmetics manufacturing, and research and development
Emergency contact numbers:
+111 (UK NHS Direct); +112 (EU Emergency)
Storage conditions:
Dry, cool area below 20°C, protected from sunlight, sealed container, well-ventilated environment
Primary risks:
Acute toxicity if swallowed, respiratory irritation from dust, potential skin and eye irritation
Fire hazards:
Possible release of carbon monoxide and carbon dioxide during combustion; dust explosion risk
Recommended extinguishing agents:
Chemical powder, carbon dioxide, or water spray
Product name:
Cannabichromene (CBC) Isolate
Product code:
M07
Brand:
Breathe Life Sciences Ltd
Company:
Breathe Life Sciences Ltd
Company address:
Grand Union Studios, 332 Ladbroke Grove, London, England, W10 5AD
Customs number:
3301.3000
Process:
Distillation and extraction
Quantity range:
1 g – 1 kg
Substance CAS number:
20675-51-8
Chemical name:
Cannabichromene – Derived from natural sources (CBC)
Chemical formula:
2-Methyl-2-(4-methylpent-3-enyl)-7-pentyl-5-chromenol
Molecular weight:
314.469
Hazard classification:
GHS07 (acute toxicity, skin and eye irritation); GHS08 (respiratory sensitization from dust)
R-phrase:
H302 Harmful if swallowed
Environmental hazard note:
Aquatic Chronic H413
Regulatory reference:
Regulation (EU) 1272/2008 (CLP)
REACH status:
Registration not required or foreseen for a later date
Intended uses:
Basic raw material for the chemical industry; cosmetics production; research and development
Emergency numbers:
+111 (UK NHS Direct); +112 (EU Emergency)
Storage conditions:
Store in original container in a dry, cool (<20°C), well-ventilated area away from incompatible materials
Personal protective equipment:
Safety eyewear, protective clothing and gloves, respiratory mask when necessary
First aid measures:
Procedures specified for ingestion, inhalation, skin contact, and eye contact
Firefighting media:
Chemical powder, carbon dioxide, or water spray
Year:
2023
Region / City:
In-house
Topic:
Residual solvents testing
Document Type:
Standard Operating Procedure
Organization:
Internal laboratory
Author:
Not specified
Target Audience:
Laboratory analysts, supervisors
Effective Period:
Ongoing
Approval Date:
Not specified
Revision Date:
Not specified
Year:
2024
Region / City:
New York
Topic:
Healthcare, Patient Safety
Document Type:
Policy
Organization / Institution:
Housing Works Inc.
Author:
Not specified
Target Audience:
Housing Works Inc. staff members, healthcare providers
Period of Validity:
From 2024
Approval Date:
Not specified
Date of Revision:
07/01/2024
Year:
2007/08
Note:
Region / City
Theme:
Quality Improvement, Patient Safety
Document Type:
Report
Product Name:
Sentinel® Special Synthetic Gear Oils
Product Line:
S-GEAR OIL Series
Document Type:
Product Data Sheet
Product Category:
Synthetic Gear Lubricants
Formulation:
Molybdenum Sulfide Compounded
Application:
Enclosed Gear Mechanisms Including Spur, Herringbone, Spiral, Bevel and Hypoid Gears
Performance Standard:
FZG Stage 12+
ISO Viscosity Grades:
32, 46, 68, 100, 150, 220, 320, 460, 680
AGMA Lubricant Numbers:
1EP, 2EP, 3EP, 4EP, 5EP, 6EP, 7EP, 8EP
USDA Rating:
H-2
Appearance:
Dark Grey
Test Methods Referenced:
ASTM D2422, D445, D2270, D97, D92, D892, D1401, D2266, D130, D665A&B, D2509
Year:
2019
Month:
January
Organisation:
British Gynaecological Cancer Society (BGCS)
Region:
United Kingdom
Field:
Gynaecological Oncology
Topic:
Sentinel Lymph Node Technique in Vulval, Cervical and Endometrial Cancer
Document Type:
Consensus Statement
Authors:
Christina Fotopoulou; Thomas Ind; Peter Baldwin; Robin Crawford; Omer Devaja; Stephen Dobbs; Jonathan Frost; Ketan Gajjar; Raji Ganesan; Sonali Kaushik; Jo Morrison; Marielle Nobbenhuis; Nithya Ratnavelu; Phil Rolland; Naveena Singh; Alexandra Taylor; Sudha Sundar; Andy Nordin
Participating Body:
BGCS officers and expert members of the UK gynaecological oncological community
Methodology:
Delphi process with two rounds and 80% consensus threshold
Scope:
Applicability, oncologic safety and surgical safety of sentinel lymph node algorithms
Cancers Addressed:
Vulval cancer; Cervical cancer; Endometrial cancer
Guidelines Considered:
European Society of Gynaecological Oncologists (ESGO)
Implementation Context:
UK gynaecological cancer centres
Clinical Focus:
Surgical staging; SLN mapping; Lymphadenectomy; Histological ultra-staging; Training and audit requirements
Year:
2020
Region / City:
Sentinel
Topic:
School Council Meeting
Document Type:
Meeting Minutes
Organization / Institution:
Sentinel Parent Advisory Council (SPAC)
Author:
Not specified
Target Audience:
Parents and staff of Sentinel
Period of Validity:
Not specified
Approval Date:
Not specified
Modification Date:
Not specified
Year:
2000–2019
Country:
Italy
Subject:
Environmental health, epidemiology, childhood cancer, chemical pollutants, air and water contamination
Document type:
Scientific articles compilation
Authors:
Lauriola P, Serafini A, Santamaria MG, Pegoraro S, Romizi F, Di Ciaula A, Terzano B, De Tommasi F, Cordiano V, Guicciardi S, Beraìnardi M, Leonardi G, Romizi R, Vinci E, Bianchi F, Parodi S, Seniori Costantini A, Crosignani P, Fontana A, Miligi L, Nanni O, Piro S, Ramazzotti V, Rodella S, Tumino R, Vindigni C, Vineis P, Stagnaro E, Corra L, De Marco C, Borgini A, Ruprecht AA, Veronese C, Mazza R, Bertoldi M, Tittarelli A, Scaburri A, Ogliari AC, Zagà V, Contiero P, Tagliabue G, Boffi R, Santarelli L, Gaetani S, Monaco F, Bracci M, Valentino M, Amati M, Rubini C, Sabbatini A, Pasquini E, Zanotta N, CVomar M, Neuzil J, Tomasetti M, Modonesi C, Oddone E, Panizza C, Imbriani M, Di Ciaula A, Alleva R, Manzella N, Bacchetti T, Ciarapica V, Borghi B, Lopomo A, Burgio E, Migliore L, Cappelletti R, Ceppi M, Claudatus J, Gennaro V, Porcile G, Ghirga G, Comba P, Tomatis L, Cantoni S, Carnevale F, Merler E, Mollo F, Ricci P, Silvestri S, Romizi R
Target audience:
Researchers, healthcare professionals, environmental policymakers
Publication period:
2000–2019
Sources:
Peer-reviewed journals, institutional reports, epidemiological studies
Topics covered:
Sentinel physician programs, chemical exposure, asbestos, PFAS, air and water pollution, obesity, epigenetics, childhood cancers, preventive medicine
Context:
Collection of peer-reviewed articles and reports detailing environmental health concerns, epidemiological findings, and proposed preventive actions in Italy, focusing on chemical, biological, and lifestyle risk factors.
Year:
2023
Country:
Gabon
Region / Cities:
Libreville, Melen, Mouila, Oyem, Bitam, Moanda
Topic:
Malaria diagnostics, epidemiology
Document type:
Original research article
Institution:
University of Health Sciences (USS), Department of Parasitology–Mycology and Tropical Medicine (SPMET)
Authors:
Bouyou Akotet et al., Ndong Ngomo et al., Mawili-Mboumba et al., Moutombi-Ditombi et al.
Target population:
Patients at sentinel sites
Study period:
February–December 2023
Diagnostic methods:
HRP2-based rapid diagnostic tests, light microscopy
Key findings:
Variation in RDT sensitivity and specificity across sites, discordance with microscopy, factors influencing RDT positivity
Keywords:
Malaria, HRP2-RDT, sensitivity, specificity, discordance, Gabon
Abstract:
Cross-sectional evaluation of HRP2-based rapid diagnostic tests for malaria at sentinel sites, highlighting variability in performance and implications for epidemiological surveillance and diagnostic capacity